Literature DB >> 27825459

Origin of Waldenstrom's macroglobulinaemia.

Ramón García-Sanz1, Cristina Jiménez2, Noemí Puig2, Bruno Paiva3, Norma C Gutiérrez2, Paula Rodríguez-Otero3, Julia Almeida4, Jesús San Miguel3, Alberto Orfão4, Marcos González2, Martín Pérez-Andrés4.   

Abstract

Waldenstrom's macroglobulinaemia (WM) is an MYD88L265P-mutated lymphoplasmacytic lymphoma that invades bone marrow and secretes monoclonal immunoglobulin M (IgM). WM cells are usually unable to undergo class switch recombination, and have mutated IGHV, with a typical immunophenotype CD19+/CD22low+/CD23-/CD25+/CD27+/CD45+/CD38low+/SmIgM+ (negative for CD5, CD10, CD11c, CD103). This immunophenotype matches memory B cells (smIgM-/+/CD10-/CD19+/CD20+/CD27+/CD38low+/CD45+), representing 30% of B cells in the blood. Fifty percent of them have not undergone class switch recombination and are IgM+. These cells have suffered somatic hypermutation as WM cells. Genetic abnormalities do not abrogate the capacity to progress to plasma cells that usually belong to the clonal WM compartment, with a normal immunophenotype and functional characteristics. However, some WM cells are CD27-, MYD88WT, without somatic hypermutation, or with class switch recombination capable of reactivation. Thus, most data support a B-memory-cell origin for WM, but a small fraction of cases may have a different origin.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  B lymphocytes; Flow cytometry; Immunophenotyping; Waldenstrom's macroglobulinaemia

Mesh:

Substances:

Year:  2016        PMID: 27825459     DOI: 10.1016/j.beha.2016.08.024

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  4 in total

1.  Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia.

Authors:  Kavita M Dhodapkar; Madhav V Dhodapkar; Akhilesh Kaushal; Ajay K Nooka; Allison R Carr; Katherine E Pendleton; Benjamin G Barwick; Julia Manalo; Samuel S McCachren; Vikas A Gupta; Nisha S Joseph; Craig C Hofmeister; Jonathan L Kaufman; Leonard T Heffner; Stephen M Ansell; Lawrence H Boise; Sagar Lonial
Journal:  Blood Cancer Discov       Date:  2021-09-01

2.  IgA-producing lymphoplasmacytic lymphoma carrying the chromosomal abnormality t(8;14).

Authors:  Yuta Gotoh; Yumi Aoyama; Hiroko Tsunemine; Yuka Idei; Ayano Mori; Taiichi Kodaka; Sachiko Iba; Akihiro Tomita; Tomoo Itoh; Takayuki Takahashi
Journal:  J Clin Exp Hematop       Date:  2019-08-08

Review 3.  KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders.

Authors:  Elena Vendramini; Riccardo Bomben; Federico Pozzo; Tamara Bittolo; Erika Tissino; Valter Gattei; Antonella Zucchetto
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

Review 4.  Current applications of multiparameter flow cytometry in plasma cell disorders.

Authors:  T Jelinek; R Bezdekova; M Zatopkova; L Burgos; M Simicek; T Sevcikova; B Paiva; R Hajek
Journal:  Blood Cancer J       Date:  2017-10-20       Impact factor: 11.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.